Company / Revenue per Share
Vivos Therapeutics, Inc. Revenue per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$2.55
FY2025
5-year range
$0.72 / $17.41
FY2021-FY2025
Trend
-66.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $17.41 to $2.55 over the past 2 years.
Based on SEC 10-K filings.
2.55 in FY2025 with a 5-year CAGR of +22.8%.
Declined from $17.41 to $2.55 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +51.5%
- 5-Year CAGR
- +22.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share decreased 66.1% year-over-year.
- Peak revenue per share was recorded in FY2023.
- Lowest revenue per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.55 | -66.1% |
| FY2024 | $7.53 | -56.8% |
| FY2023 | $17.41 | +2272.2% |
| FY2022 | $0.73 | +2.3% |
| FY2021 | $0.72 | -21.6% |
| FY2020 | $0.92 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026